These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19229867)

  • 1. Two potent transactivation domains in the C-terminal region of human NANOG mediate transcriptional activation in human embryonic carcinoma cells.
    Do HJ; Lee WY; Lim HY; Oh JH; Kim DK; Kim JH; Kim T; Kim JH
    J Cell Biochem; 2009 Apr; 106(6):1079-89. PubMed ID: 19229867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a putative transactivation domain in human Nanog.
    Oh JH; Do HJ; Yang HM; Moon SY; Cha KY; Chung HM; Kim JH
    Exp Mol Med; 2005 Jun; 37(3):250-4. PubMed ID: 16000880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the human NANOG protein.
    Chang DF; Tsai SC; Wang XC; Xia P; Senadheera D; Lutzko C
    Stem Cells; 2009 Apr; 27(4):812-21. PubMed ID: 19350681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.
    Pan G; Pei D
    J Biol Chem; 2005 Jan; 280(2):1401-7. PubMed ID: 15502159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog.
    Pan GJ; Pei DQ
    Cell Res; 2003 Dec; 13(6):499-502. PubMed ID: 14728807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intact homeobox domain is required for complete nuclear localization of human Nanog.
    Do HJ; Lim HY; Kim JH; Song H; Chung HM; Kim JH
    Biochem Biophys Res Commun; 2007 Feb; 353(3):770-5. PubMed ID: 17196939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional characterization of an alternative splice variant within the fourth exon of human nanog.
    Kim JS; Kim J; Kim BS; Chung HY; Lee YY; Park CS; Lee YS; Lee YH; Chung IY
    Exp Mol Med; 2005 Dec; 37(6):601-7. PubMed ID: 16391521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
    Santagata S; Ligon KL; Hornick JL
    Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
    You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
    Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells.
    Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH
    FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human.
    Hart AH; Hartley L; Ibrahim M; Robb L
    Dev Dyn; 2004 May; 230(1):187-98. PubMed ID: 15108323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal pentapeptide of Nanog tryptophan repeat domain interacts with Nac1 and regulates stem cell proliferation but not pluripotency.
    Ma T; Wang Z; Guo Y; Pei D
    J Biol Chem; 2009 Jun; 284(24):16071-16081. PubMed ID: 19366700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells.
    Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH
    Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEST motif sequence regulating human NANOG for proteasomal degradation.
    Ramakrishna S; Suresh B; Lim KH; Cha BH; Lee SH; Kim KS; Baek KH
    Stem Cells Dev; 2011 Sep; 20(9):1511-9. PubMed ID: 21299413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of human OCT4 transactivation domains for self-regulatory transcription.
    Lim HY; Do HJ; Lee WY; Kim DK; Seo HG; Chung HJ; Park JK; Chang WK; Kim JH; Kim JH
    Biochem Biophys Res Commun; 2009 Jul; 385(2):148-53. PubMed ID: 19445899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression.
    Kuroda T; Tada M; Kubota H; Kimura H; Hatano SY; Suemori H; Nakatsuji N; Tada T
    Mol Cell Biol; 2005 Mar; 25(6):2475-85. PubMed ID: 15743839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes.
    Boer B; Kopp J; Mallanna S; Desler M; Chakravarthy H; Wilder PJ; Bernadt C; Rizzino A
    Nucleic Acids Res; 2007; 35(6):1773-86. PubMed ID: 17324942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA 630 Represses NANOG Expression through Transcriptional and Post-Transcriptional Regulation in Human Embryonal Carcinoma Cells.
    Chu WK; Hung LM; Hou CW; Chen JK
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.
    Chan KK; Zhang J; Chia NY; Chan YS; Sim HS; Tan KS; Oh SK; Ng HH; Choo AB
    Stem Cells; 2009 Sep; 27(9):2114-25. PubMed ID: 19522013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma.
    Ezeh UI; Turek PJ; Reijo RA; Clark AT
    Cancer; 2005 Nov; 104(10):2255-65. PubMed ID: 16228988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.